Christopher Andrew Barker MD
Melanoma, Ocular Radiation Oncology, Skin Cancer
Vice Chair for Clinical Research, Associate Attending
1275 York AvenueNew York, NY 10065
Overview of Dr. Barker
Christopher Barker, MD, is a radiation oncologist based in New York, NY, with a focus on melanoma, ocular radiation oncology, and skin cancer. He completed his medical education at the University of Florida College of Medicine in 2006 and his residency in radiation oncology at Memorial Sloan Kettering Cancer Center, where he is currently employed. Dr. Barker has clinical expertise in squamous cell carcinoma, mycosis fungoides, malignant melanoma, brachytherapy, and Kaposi's sarcoma. He has contributed to several publications on topics including cutaneous squamous cell carcinoma and Merkel cell carcinoma. Additionally, he has been involved in clinical trials addressing the treatment of solid tumors, skin cancer, and mucosal melanoma. He received CMS Meaningful Use Stage 1 Certification from Sunrise Ambulatory Care and MyMSK.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2007 - 2011- Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2006 - 2007
University of Florida College of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2022 - Present
CT State Medical License 2024 - 2027
NJ State Medical License 2015 - 2027
NY State Medical License 2007 - 2027
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Adjuvant radiation for major salivary gland adenoid cystic carcinoma in the modern era: updated patterns of care and survival from the National Cancer Database (2004-2...Nishant Chadha, George Ashji, Sudarshan Ramanan, Edward Christopher Dee, Yingzhi Wu
Oral Oncology. 2026-10-01 - A phase II randomized study of proton therapy vs intensity-modulated radiation therapy in patients with unilateral head and neck cancer.Edward Christopher Dee, Noah S Kalman, Daniel J Ma, Scott C Lester, Zhigang Zhang
Journal of the National Cancer Institute. 2026-09-03 - Long-term local control and cosmesis of electronic skin surface brachytherapy for basal cell carcinoma: A prospective multicenter study.Hesham Alshaikh, Miguel A Cordova, Ming Lian, Omar Alani, Zhang Zhigang
Journal of the American Academy of Dermatology. 2026-09-01
Press Mentions
Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCCMarch 2nd, 2024
Professional Memberships
- Member
- Member
- Member
Insurance Accepted
- BCBS Blue Card PPO
CIGNA PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health FreedomOxford Health Liberty
QualCare HMO
QualCare PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: